Bionik Laboratories Corp. – OTC:BNKL

Founder-led company

Bionik Laboratories Corp. stock price today

$0.623
+0.62
+6224900%
Financial Health
0
1
2
3
4
5
6
7
8
9

Bionik Laboratories Corp. stock price monthly change

-100.00%
month

Bionik Laboratories Corp. stock price quarterly change

-100.00%
quarter

Bionik Laboratories Corp. stock price yearly change

-100.00%
year

Bionik Laboratories Corp. key metrics

Market Cap
 4.20M
Enterprise value
 5.42M
P/E
 -0.77
EV/Sales
 3.62
EV/EBITDA
 -1.09
Price/Sales
 2.85
Price/Book
 -8.18
PEG ratio
 -0.02
EPS
 -2.83
Revenue
 1.10M
EBITDA
 -5.25M
Income
 -16.87M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 -354.09%
Oper. margin
 -329.64%
Gross margin
 58.07%
EBIT margin
 -329.64%
EBITDA margin
 -476.21%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Bionik Laboratories Corp. stock price history

Bionik Laboratories Corp. stock forecast

Bionik Laboratories Corp. financial statements

Profit Margin

Bionik Laboratories Corp. (OTC:BNKL): Profit margin
Sep 2021 227.90K -1.26M -556.37%
Dec 2021 183.26K -12.18M -6648.65%
Mar 2022 191.26K -2.00M -1050.5%
Mar 2023 501.11K -1.41M -282.46%
BNKL income statement history

Debt to Assets

Bionik Laboratories Corp. (OTC:BNKL): Debt to assets
Jun 2022 4002988 2.40M 60.11%
Sep 2022 3830054 3.30M 86.34%
Dec 2022 3685155 4.20M 114.16%
Mar 2023 3362127 5.00M 148.8%
BNKL balance sheet history

Cash Flow

Bionik Laboratories Corp. (OTC:BNKL): Cash Flow
Sep 2021 -757.71K 0 5M
Dec 2021 -1.39M -12.5K -1.43K
Mar 2022 -1.37M 0 1.43K
Mar 2023 -756.94K -752 500K
BNKL cash flow history

Bionik Laboratories Corp. alternative data

Bionik Laboratories Corp.
Employees

Bionik Laboratories Corp. (OTC:BNKL): Employee count
Aug 2023 12
Sep 2023 12
Oct 2023 12
Nov 2023 12
Dec 2023 12
Jan 2024 12
Feb 2024 12
Mar 2024 12
Apr 2024 12
May 2024 12
Jun 2024 12
Jul 2024 12

Bionik Laboratories Corp. other data

Bionik Laboratories Corp.
Insider Trading

Bionik Laboratories Corp. (OTC:BNKL): Insider trades (number of shares)
Period Buy Sel
Mar 2021 200869 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
MALONE PETER GERALD director
 Common Stock, par value $0.001 per share 26,430 N/A N/A
Purchase
MATINE CHARLES director
 Common Stock, par value $0.001 per share 26,430 N/A N/A
Purchase
THEVENON AUDREY director
 Common Stock, par value $0.001 per share 26,430 N/A N/A
Purchase
MARTIN JOSEPH R director
 Common Stock, par value $0.001 per share 26,430 N/A N/A
Purchase
AUBERTON-HERVE ANDRE-JACQUES director
 Common Stock, par value $0.001 per share 95,149 N/A N/A
Purchase
GASTON-DREYFUS REMI director, 10 percent owner
 Common Stock 106,358 $3.76 $399,906
Sale
CAIRES THIAGO MORAIS ULHOA director, 10 percent owner, off..
 Exchangeable Shares 210,761 N/A N/A
Sale
PRYWATA MICHAL director, officer.. Exchangeable Shares 210,761 N/A N/A
Sale
BLOCH PETER D. director, officer: Chairman and..
 Exchangeable Shares 207,616 N/A N/A
Sale
ARCHAMBAUD OLIVIER RENE PIERRE 10 percent owner
 Exchangeable Shares 629,138 N/A N/A
BNKL insider trading transactions

Frequently Asked Questions (FAQ)

  • What's the price of Bionik Laboratories Corp. stock today?

    One share of Bionik Laboratories Corp. stock can currently be purchased for approximately $0.62.

  • When is Bionik Laboratories Corp.'s next earnings date?

    Unfortunately, Bionik Laboratories Corp.'s (BNKL) next earnings date is currently unknown.

  • Does Bionik Laboratories Corp. pay dividends?

    No, Bionik Laboratories Corp. does not pay dividends.

  • How much money does Bionik Laboratories Corp. make?

    Bionik Laboratories Corp. has a market capitalization of 4.20M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 41.73% to 1.81M US dollars.

  • What is Bionik Laboratories Corp.'s stock symbol?

    Bionik Laboratories Corp. is traded on the OTC under the ticker symbol "BNKL".

  • What is Bionik Laboratories Corp.'s primary industry?

    Company operates in the Healthcare sector and Medical Care Facilities industry.

  • How do i buy shares of Bionik Laboratories Corp.?

    Shares of Bionik Laboratories Corp. can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Bionik Laboratories Corp.'s key executives?

    Bionik Laboratories Corp.'s management team includes the following people:

    • Mr. Richard Paul Russo Jr., CPA Chief Financial Officer & Interim Chief Executive Officer(age: 44, pay: $265,820)
    • Mr. Loren W. Wass Chief Commercial Officer(age: 63, pay: $259,540)
    • Mr. Michal Prywata Co-Founder & Director(age: 34, pay: $169,970)

  • Is Bionik Laboratories Corp. founder-led company?

    Yes, Bionik Laboratories Corp. is a company led by its founder Mr. Michal Prywata.

  • How many employees does Bionik Laboratories Corp. have?

    As Jul 2024, Bionik Laboratories Corp. employs 12 workers.

  • When Bionik Laboratories Corp. went public?

    Bionik Laboratories Corp. is publicly traded company for more then 13 years since IPO on 12 Jun 2012.

  • What is Bionik Laboratories Corp.'s official website?

    The official website for Bionik Laboratories Corp. is bioniklabs.com.

  • Where are Bionik Laboratories Corp.'s headquarters?

    Bionik Laboratories Corp. is headquartered at N105, 483 Bay St, TORONTO, ONTARIO.

  • How can i contact Bionik Laboratories Corp.?

    Bionik Laboratories Corp.'s mailing address is N105, 483 Bay St, TORONTO, ONTARIO and company can be reached via phone at +1 416 640 7887.

Bionik Laboratories Corp. company profile:

Bionik Laboratories Corp.

bioniklabs.com
Exchange:

OTC

Full time employees:

12

Industry:

Medical Care Facilities

Sector:

Healthcare

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.

+1 416 640 7887
N105, 483 Bay St
TORONTO, ONTARIO 02472

CIK: 0001508381
ISIN: US09074A2087
CUSIP: 09074A208